Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-14-048869

← back to feed
Filed
Aug 12, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 9, 2014 21.63M sh
Stockholders Equity Q2 2014 · Jun 30, 2014 −$4.32M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$3.12M
Current Liabilities Q2 2014 · Jun 30, 2014 $4.42M
Current Liabilities Q2 2014 · Dec 31, 2013 $3.22M
Current Assets Q2 2014 · Jun 30, 2014 $99.53K
Current Assets Q2 2014 · Dec 31, 2013 $95.84K
Total Assets Q2 2014 · Jun 30, 2014 $99.53K
Total Assets Q2 2014 · Dec 31, 2013 $96.32K
Short Term Debt Q2 2014 · Apr 30, 2014 $100K
Cash And Equivalents Q2 2014 · Jun 30, 2013 $121.71K
Cash And Equivalents Q2 2014 · Dec 31, 2012 $511.69K
Sga Expense Q2 2014 · Jun 30, 2013 $135.7K
Sga Expense Q2 2014 · Jun 30, 2013 $292.53K
Rd Expense Q2 2014 · Jun 30, 2013 $215.72K
Rd Expense Q2 2014 · Jun 30, 2013 $453.54K
Net Income Q2 2014 · Jun 30, 2013 −$257.36K
Net Income Q2 2014 · Jun 30, 2013 −$705.55K
Operating Income Q2 2014 · Jun 30, 2013 −$351.42K
Operating Income Q2 2014 · Jun 30, 2013 −$746.07K
Revenue Q2 2014 · Jun 30, 2013 $0
Revenue Q2 2014 · Jun 30, 2013 $0